Giraffe Incubator Ohmeda Medical Giraffe Incubator-The Giraffe Incubator is an infant incubator....

FDA Device Recall #Z-1505-2017 — Class II — November 18, 2016

Recall Summary

Recall Number Z-1505-2017
Classification Class II — Moderate risk
Date Initiated November 18, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Ohmeda Medical
Location Laurel, MD
Product Type Devices
Quantity 5,993 (5,080 US; 913 OUS)

Product Description

Giraffe Incubator Ohmeda Medical Giraffe Incubator-The Giraffe Incubator is an infant incubator. Incubators provide heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. They achieve this by providing an enclosed temperature controlled environment for the infant. This device may incorporate a Servo Controlled Oxygen Delivery System. This is indicated to provide a stable oxygen concentration within the infant compartment at the value set by the operator (21-65%).

Reason for Recall

Certain power cords could overheat. The affected power cords were manufactured by Electric-Cord and are referred to as Taller Bridge power cords. The overheating of the power cord could result in fire, charring, smoke, or sparking where the power cord connects to the wall outlet which could cause thermal injury.

Distribution Pattern

Worldwide Distribution - US (nationwide and Puerto Rico) Bahamas and Internationally to UK, Trinidad & Tobago, Taiwan, Spain, Panama, Netherlands Antilles, Mexico, Lebanon, Japan, Ireland, Honduras, El Salvador, Ecuador, Costa Rica, Colombia, Canada, Brazil, and Venezuela,

Lot / Code Information

See Attached Spreadsheat

Other Recalls from Ohmeda Medical

Recall # Classification Product Date
Z-0041-2020 Class II Giraffe Omnibed - Product Usage: The OmniBed is... Oct 5, 2018
Z-1181-2018 Class II Rotating IV Pole Rotating IV Pole falls un... Dec 1, 2017
Z-1509-2017 Class II Giraffe OmniBed Ohmeda Medical Omnibed- The Om... Nov 18, 2016
Z-1502-2017 Class II Giraffe Incubator The Giraffe Incubator is an ... Nov 18, 2016
Z-1511-2017 Class II IWS Infant Warmer System-Infant radiant warmer... Nov 18, 2016

Frequently Asked Questions

Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.